Utah Medical Products UTMD Obstetrics — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's obstetrics — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's obstetrics — revenue?
- Utah Medical Products (UTMD) reported obstetrics — revenue of $905K in Q1 2026.
- How has Utah Medical Products's obstetrics — revenue changed year-over-year?
- Utah Medical Products's obstetrics — revenue decreased by 11.7% year-over-year, from $1.03M to $905K.
- What is the long-term trend for Utah Medical Products's obstetrics — revenue?
- Over 4 years (2021 to 2025), Utah Medical Products's obstetrics — revenue has grown at a -3.1% compound annual growth rate (CAGR), from $5.41M to $4.76M.
- What does obstetrics — revenue mean?
- This metric represents the total net sales generated from the sale of medical devices and supplies specifically within the obstetrics product category. It reflects the company's ability to monetize its proprietary gynecological and perinatology product lines through direct contracts with healthcare providers. Monitoring this figure helps investors assess the market demand and competitive positioning of the firm's specialized maternal and neonatal care offerings.